Bevacizumab May Differentially Improve Prognosis of Advanced Ovarian Cancer Patients with Low Expression of VEGF-A165b, an Antiangiogenic VEGF-A Splice Variant.
Wimberger P, Gerber MJ, Pfisterer J, Erdmann K, Füssel S, Link T, du Bois A, Kommoss S, Heitz F, Sehouli J, Kimmig R, de Gregorio N, Schmalfeldt B, Park-Simon TW, Baumann K, Hilpert F, Grube M, Schröder W, Burges A, Belau A, Hanker L, Kuhlmann JD.
Wimberger P, et al. Among authors: gerber mj.
Clin Cancer Res. 2022 Nov 1;28(21):4660-4668. doi: 10.1158/1078-0432.CCR-22-1326.
Clin Cancer Res. 2022.
PMID: 36001383